25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

JB Chemicals & Pharmaceuticals Limited
Buy, Hold or Sell?

Let's analyze JB Chemicals & Pharmaceuticals Limited together

I guess you are interested in JB Chemicals & Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of JB Chemicals & Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about JB Chemicals & Pharmaceuticals Limited

I send you an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited.

1. Quick Overview

1.1. Quick analysis of JB Chemicals & Pharmaceuticals Limited (30 sec.)










1.2. What can you expect buying and holding a share of JB Chemicals & Pharmaceuticals Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.47
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR185.16
Expected worth in 1 year
INR292.30
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR146.92
Return On Investment
7.5%

For what price can you sell your share?

Current Price per Share
INR1,961.05
Expected price per share
INR1,684 - INR1,992
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of JB Chemicals & Pharmaceuticals Limited (5 min.)




Live pricePrice per Share (EOD)
INR1,961.05
Intrinsic Value Per Share
INR83.33 - INR246.39
Total Value Per Share
INR268.49 - INR431.55

2.2. Growth of JB Chemicals & Pharmaceuticals Limited (5 min.)




Is JB Chemicals & Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$347.8m$295.1m$52.7m15.2%

How much money is JB Chemicals & Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money$65.7m$48.7m$16.9m25.8%
Net Profit Margin15.9%13.0%--

How much money comes from the company's main activities?

2.3. Financial Health of JB Chemicals & Pharmaceuticals Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of JB Chemicals & Pharmaceuticals Limited?

Welcome investor! JB Chemicals & Pharmaceuticals Limited's management wants to use your money to grow the business. In return you get a share of JB Chemicals & Pharmaceuticals Limited.

First you should know what it really means to hold a share of JB Chemicals & Pharmaceuticals Limited. And how you can make/lose money.

Speculation

The Price per Share of JB Chemicals & Pharmaceuticals Limited is INR1,961. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of JB Chemicals & Pharmaceuticals Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in JB Chemicals & Pharmaceuticals Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR185.16. Based on the TTM, the Book Value Change Per Share is INR26.79 per quarter. Based on the YOY, the Book Value Change Per Share is INR20.67 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR9.94 per quarter.
Based on historical numbers we can estimate the returns while holding a share of JB Chemicals & Pharmaceuticals Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.420.0%0.420.0%0.310.0%0.310.0%0.220.0%
Usd Book Value Change Per Share0.320.0%0.320.0%0.250.0%0.210.0%0.140.0%
Usd Dividend Per Share0.120.0%0.120.0%0.100.0%0.090.0%0.070.0%
Usd Total Gains Per Share0.440.0%0.440.0%0.340.0%0.310.0%0.210.0%
Usd Price Per Share19.64-19.64-23.31-16.54-10.00-
Price to Earnings Ratio47.14-47.14-74.86-51.76-40.52-
Price-to-Total Gains Ratio44.92-44.92-67.97-68.59-35.97-
Price to Book Ratio8.91-8.91-12.37-9.82-6.67-
Price-to-Total Gains Ratio44.92-44.92-67.97-68.59-35.97-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share23.336495
Number of shares42
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.120.09
Usd Book Value Change Per Share0.320.21
Usd Total Gains Per Share0.440.31
Gains per Quarter (42 shares)18.3612.95
Gains per Year (42 shares)73.4351.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1205463163642
240107136327294
36016120948108146
48021428264143198
59926835580179250
611932142896215302
7139375501112251354
8159428574128287406
9179482647144323458
10199536720159359510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%17.02.00.089.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%18.01.00.094.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of JB Chemicals & Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--26.78726.7870%20.674+30%17.935+49%11.801+127%
Book Value Per Share--185.157185.1570%158.370+17%137.671+34%109.935+68%
Current Ratio--2.1352.1350%2.756-23%3.228-34%3.123-32%
Debt To Asset Ratio--0.2680.2680%0.302-11%0.229+17%0.231+16%
Debt To Equity Ratio--0.3660.3660%0.433-15%0.303+21%0.309+19%
Dividend Per Share--9.9439.9430%8.147+22%7.976+25%5.624+77%
Eps--35.00235.0020%26.168+34%26.384+33%18.207+92%
Free Cash Flow Per Share--31.61431.6140%-8.897+128%3.615+774%3.552+790%
Free Cash Flow To Equity Per Share--9.9989.9980%13.868-28%-2.909+129%-3.050+131%
Gross Profit Margin--0.3090.3090%0.559-45%0.435-29%0.269+15%
Intrinsic Value_10Y_max--246.394--------
Intrinsic Value_10Y_min--83.330--------
Intrinsic Value_1Y_max--8.177--------
Intrinsic Value_1Y_min---0.854--------
Intrinsic Value_3Y_max--37.154--------
Intrinsic Value_3Y_min--5.391--------
Intrinsic Value_5Y_max--81.304--------
Intrinsic Value_5Y_min--20.308--------
Market Cap304578519700.000+14%260508864000.000260508864000.0000%306807605860.160-15%217597400872.352+20%131414903860.176+98%
Net Profit Margin--0.1590.1590%0.130+22%0.165-4%0.142+12%
Operating Margin--0.2180.2180%0.878-75%0.345-37%0.250-13%
Operating Ratio--0.7820.7820%0.566+38%0.746+5%0.807-3%
Pb Ratio10.591+16%8.9118.9110%12.370-28%9.823-9%6.667+34%
Pe Ratio56.027+16%47.14047.1400%74.862-37%51.758-9%40.518+16%
Price Per Share1961.050+16%1650.0001650.0000%1958.960-16%1389.772+19%840.502+96%
Price To Free Cash Flow Ratio62.032+16%52.19352.1930%-220.186+522%-20.011+138%10.581+393%
Price To Total Gains Ratio53.391+16%44.92244.9220%67.971-34%68.592-35%35.968+25%
Quick Ratio--1.7421.7420%1.959-11%2.801-38%2.920-40%
Return On Assets--0.1380.1380%0.115+20%0.150-8%0.122+13%
Return On Equity--0.1890.1890%0.165+14%0.194-3%0.158+19%
Total Gains Per Share--36.73036.7300%28.820+27%25.912+42%17.426+111%
Usd Book Value--347876270.000347876270.0000%295161650.000+18%256890371.780+35%204406529.670+70%
Usd Book Value Change Per Share--0.3190.3190%0.246+30%0.213+49%0.140+127%
Usd Book Value Per Share--2.2032.2030%1.885+17%1.638+34%1.308+68%
Usd Dividend Per Share--0.1180.1180%0.097+22%0.095+25%0.067+77%
Usd Eps--0.4170.4170%0.311+34%0.314+33%0.217+92%
Usd Free Cash Flow--59396470.00059396470.0000%-16581460.000+128%6962718.560+753%6705467.930+786%
Usd Free Cash Flow Per Share--0.3760.3760%-0.106+128%0.043+774%0.042+790%
Usd Free Cash Flow To Equity Per Share--0.1190.1190%0.165-28%-0.035+129%-0.036+131%
Usd Market Cap3624484384.430+14%3100055481.6003100055481.6000%3651010509.736-15%2589409070.381+20%1563837355.936+98%
Usd Price Per Share23.336+16%19.63519.6350%23.312-16%16.538+19%10.002+96%
Usd Profit--65762708.20065762708.2000%48770424.500+35%49214449.200+34%33867271.480+94%
Usd Revenue--414617420.000414617420.0000%374764320.000+11%304788885.660+36%230014455.020+80%
Usd Total Gains Per Share--0.4370.4370%0.343+27%0.308+42%0.207+111%
 EOD+4 -4MRQTTM+0 -0YOY+24 -125Y+23 -1310Y+27 -9

3.3 Fundamental Score

Let's check the fundamental score of JB Chemicals & Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1556.027
Price to Book Ratio (EOD)Between0-110.591
Net Profit Margin (MRQ)Greater than00.159
Operating Margin (MRQ)Greater than00.218
Quick Ratio (MRQ)Greater than11.742
Current Ratio (MRQ)Greater than12.135
Debt to Asset Ratio (MRQ)Less than10.268
Debt to Equity Ratio (MRQ)Less than10.366
Return on Equity (MRQ)Greater than0.150.189
Return on Assets (MRQ)Greater than0.050.138
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of JB Chemicals & Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.791
Ma 20Greater thanMa 501,852.905
Ma 50Greater thanMa 1001,885.058
Ma 100Greater thanMa 2001,863.386
OpenGreater thanClose1,865.600
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About JB Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-10-27 06:02:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit JB Chemicals & Pharmaceuticals Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 15.9% means that ₹0.16 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 15.9%. The company is making a huge profit. +2
  • The TTM is 15.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.9%TTM15.9%0.0%
TTM15.9%YOY13.0%+2.8%
TTM15.9%5Y16.5%-0.7%
5Y16.5%10Y14.2%+2.3%
4.3.1.2. Return on Assets

Shows how efficient JB Chemicals & Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 13.8% Return on Assets means that JB Chemicals & Pharmaceuticals Limited generated ₹0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 13.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 13.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ13.8%TTM13.8%0.0%
TTM13.8%YOY11.5%+2.3%
TTM13.8%5Y15.0%-1.2%
5Y15.0%10Y12.2%+2.8%
4.3.1.3. Return on Equity

Shows how efficient JB Chemicals & Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 18.9% Return on Equity means JB Chemicals & Pharmaceuticals Limited generated ₹0.19 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 18.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.9%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.9%TTM18.9%0.0%
TTM18.9%YOY16.5%+2.4%
TTM18.9%5Y19.4%-0.5%
5Y19.4%10Y15.8%+3.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of JB Chemicals & Pharmaceuticals Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient JB Chemicals & Pharmaceuticals Limited is operating .

  • Measures how much profit JB Chemicals & Pharmaceuticals Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 21.8% means the company generated ₹0.22  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 21.8%. The company is operating efficient. +1
  • The TTM is 21.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.8%TTM21.8%0.0%
TTM21.8%YOY87.8%-66.0%
TTM21.8%5Y34.5%-12.7%
5Y34.5%10Y25.0%+9.5%
4.3.2.2. Operating Ratio

Measures how efficient JB Chemicals & Pharmaceuticals Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are ₹0.78 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.782. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.782. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.782TTM0.7820.000
TTM0.782YOY0.566+0.216
TTM0.7825Y0.746+0.037
5Y0.74610Y0.807-0.062
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of JB Chemicals & Pharmaceuticals Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.13 means the company has ₹2.13 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 2.135. The company is able to pay all its short-term debts. +1
  • The TTM is 2.135. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.135TTM2.1350.000
TTM2.135YOY2.756-0.621
TTM2.1355Y3.228-1.093
5Y3.22810Y3.123+0.105
4.4.3.2. Quick Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.74 means the company can pay off ₹1.74 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 1.742. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.742. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.742TTM1.7420.000
TTM1.742YOY1.959-0.217
TTM1.7425Y2.801-1.059
5Y2.80110Y2.920-0.120
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of JB Chemicals & Pharmaceuticals Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of JB Chemicals & Pharmaceuticals Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that JB Chemicals & Pharmaceuticals Limited assets are financed with 26.8% credit (debt) and the remaining percentage (100% - 26.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.268. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.268. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.268TTM0.2680.000
TTM0.268YOY0.302-0.034
TTM0.2685Y0.229+0.039
5Y0.22910Y0.231-0.002
4.5.4.2. Debt to Equity Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 36.6% means that company has ₹0.37 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.366. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.366. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.366TTM0.3660.000
TTM0.366YOY0.433-0.067
TTM0.3665Y0.303+0.063
5Y0.30310Y0.309-0.006
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings JB Chemicals & Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 47.14 means the investor is paying ₹47.14 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 56.027. Based on the earnings, the company is expensive. -2
  • The MRQ is 47.140. Based on the earnings, the company is overpriced. -1
  • The TTM is 47.140. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD56.027MRQ47.140+8.887
MRQ47.140TTM47.1400.000
TTM47.140YOY74.862-27.722
TTM47.1405Y51.758-4.618
5Y51.75810Y40.518+11.240
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 62.032. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 52.193. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 52.193. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD62.032MRQ52.193+9.839
MRQ52.193TTM52.1930.000
TTM52.193YOY-220.186+272.379
TTM52.1935Y-20.011+72.204
5Y-20.01110Y10.581-30.593
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of JB Chemicals & Pharmaceuticals Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 8.91 means the investor is paying ₹8.91 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 10.591. Based on the equity, the company is expensive. -2
  • The MRQ is 8.911. Based on the equity, the company is overpriced. -1
  • The TTM is 8.911. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.591MRQ8.911+1.680
MRQ8.911TTM8.9110.000
TTM8.911YOY12.370-3.458
TTM8.9115Y9.823-0.912
5Y9.82310Y6.667+3.156
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets39,941,300
Total Liabilities10,708,000
Total Stockholder Equity29,233,300
 As reported
Total Liabilities 10,708,000
Total Stockholder Equity+ 29,233,300
Total Assets = 39,941,300

Assets

Total Assets39,941,300
Total Current Assets18,533,500
Long-term Assets21,407,800
Total Current Assets
Cash And Cash Equivalents 955,400
Short-term Investments 3,646,500
Net Receivables 6,876,200
Inventory 5,025,100
Other Current Assets 2,030,300
Total Current Assets  (as reported)18,533,500
Total Current Assets  (calculated)18,533,500
+/-0
Long-term Assets
Property Plant Equipment 6,348,800
Goodwill 574,600
Intangible Assets 13,884,600
Long-term Assets Other 198,400
Long-term Assets  (as reported)21,407,800
Long-term Assets  (calculated)21,006,400
+/- 401,400

Liabilities & Shareholders' Equity

Total Current Liabilities8,682,300
Long-term Liabilities2,025,700
Total Stockholder Equity29,233,300
Total Current Liabilities
Short-term Debt 3,443,800
Short Long Term Debt 3,335,000
Accounts payable 3,563,100
Other Current Liabilities 1,557,800
Total Current Liabilities  (as reported)8,682,300
Total Current Liabilities  (calculated)11,899,700
+/- 3,217,400
Long-term Liabilities
Long term Debt 236,400
Capital Lease Obligations 205,200
Long-term Liabilities Other 17,000
Long-term Liabilities  (as reported)2,025,700
Long-term Liabilities  (calculated)458,600
+/- 1,567,100
Total Stockholder Equity
Common Stock155,200
Retained Earnings 25,132,989
Accumulated Other Comprehensive Income 29,078,100
Other Stockholders Equity -25,132,989
Total Stockholder Equity (as reported)29,233,300
Total Stockholder Equity (calculated)29,233,300
+/-0
Other
Capital Stock155,200
Cash and Short Term Investments 4,601,900
Common Stock Shares Outstanding 157,884
Current Deferred Revenue117,600
Liabilities and Stockholders Equity 39,941,300
Net Debt 2,821,200
Net Invested Capital 32,804,700
Net Working Capital 9,851,200
Property Plant and Equipment Gross 6,348,800
Short Long Term Debt Total 3,776,600



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-31
> Total Assets 
5,052,762
7,122,927
7,413,071
7,463,139
8,369,680
9,993,796
11,977,989
13,002,000
13,510,132
14,872,470
15,573,841
16,740,386
17,648,899
17,910,005
18,135,611
22,381,152
26,074,022
35,538,700
39,941,300
39,941,30035,538,70026,074,02222,381,15218,135,61117,910,00517,648,89916,740,38615,573,84114,872,47013,510,13213,002,00011,977,9899,993,7968,369,6807,463,1397,413,0717,122,9275,052,762
   > Total Current Assets 
3,550,632
4,545,832
4,722,061
4,854,194
5,658,391
6,522,531
8,662,190
9,437,068
9,806,452
10,830,163
7,777,559
7,948,902
10,469,978
10,495,753
10,727,284
15,526,024
12,748,550
15,280,300
18,533,500
18,533,50015,280,30012,748,55015,526,02410,727,28410,495,75310,469,9787,948,9027,777,55910,830,1639,806,4529,437,0688,662,1906,522,5315,658,3914,854,1944,722,0614,545,8323,550,632
       Cash And Cash Equivalents 
116,003
203,857
149,609
438,454
778,619
1,268,857
2,195,325
137,242
85,557
164,081
119,999
87,447
279,428
353,968
290,079
286,855
565,441
769,300
955,400
955,400769,300565,441286,855290,079353,968279,42887,447119,999164,08185,557137,2422,195,3251,268,857778,619438,454149,609203,857116,003
       Short-term Investments 
265,036
373,136
601,316
579,992
596,819
681,148
2,989,218
3,979,792
4,972,588
5,559,545
1,952,490
2,249,616
3,837,660
3,606,499
3,338,126
6,649,748
1,062
2,159,300
3,646,500
3,646,5002,159,3001,0626,649,7483,338,1263,606,4993,837,6602,249,6161,952,4905,559,5454,972,5883,979,7922,989,218681,148596,819579,992601,316373,136265,036
       Net Receivables 
0
0
3,224,221
3,028,007
0
0
1,360,511
4,274,686
32,485
16,871
29,568
2,726,746
4,215,577
4,068,369
3,613,525
4,186,725
6,238,844
5,771,700
6,876,200
6,876,2005,771,7006,238,8444,186,7253,613,5254,068,3694,215,5772,726,74629,56816,87132,4854,274,6861,360,511003,028,0073,224,22100
       Inventory 
643,061
835,724
746,914
807,740
834,715
1,116,701
1,010,324
1,045,349
1,344,002
1,502,733
1,879,833
2,001,686
2,137,314
2,437,576
2,746,697
3,474,468
4,099,611
4,304,900
5,025,100
5,025,1004,304,9004,099,6113,474,4682,746,6972,437,5762,137,3142,001,6861,879,8331,502,7331,344,0021,045,3491,010,3241,116,701834,715807,740746,914835,724643,061
       Other Current Assets 
2,526,532
3,133,115
1
1
3,448,238
3,455,825
1,106,812
-1
3,371,820
3,586,933
3,795,669
883,407
-1
29,341
4,352,382
928,228
1,843,592
2,275,100
2,030,300
2,030,3002,275,1001,843,592928,2284,352,38229,341-1883,4073,795,6693,586,9333,371,820-11,106,8123,455,8253,448,238113,133,1152,526,532
   > Long-term Assets 
1,502,130
2,577,095
2,691,010
2,608,945
2,711,289
3,471,265
3,315,799
3,564,932
3,703,680
4,042,307
7,796,275
8,791,484
7,178,921
7,414,252
7,408,327
6,855,128
13,325,472
20,258,400
21,407,800
21,407,80020,258,40013,325,4726,855,1287,408,3277,414,2527,178,9218,791,4847,796,2754,042,3073,703,6803,564,9323,315,7993,471,2652,711,2892,608,9452,691,0102,577,0951,502,130
       Property Plant Equipment 
1,473,033
2,333,078
2,443,042
2,327,138
2,263,795
2,446,563
2,791,903
3,001,133
3,316,237
3,590,570
5,018,973
6,010,328
5,811,134
5,595,066
5,841,966
5,696,550
5,668,159
5,764,200
6,348,800
6,348,8005,764,2005,668,1595,696,5505,841,9665,595,0665,811,1346,010,3285,018,9733,590,5703,316,2373,001,1332,791,9032,446,5632,263,7952,327,1382,443,0422,333,0781,473,033
       Goodwill 
0
169,023
169,023
169,023
169,023
169,023
0
169,023
169,023
169,023
531,400
531,400
531,400
531,400
531,400
574,592
574,592
574,600
574,600
574,600574,600574,592574,592531,400531,400531,400531,400531,400169,023169,023169,0230169,023169,023169,023169,023169,0230
       Long Term Investments 
0
0
0
0
0
0
0
0
27,480
1,848,283
2,333,940
1,859,738
499,579
958,756
0
0
0
0
0
00000958,756499,5791,859,7382,333,9401,848,28327,48000000000
       Intangible Assets 
0
70
3,715
37,099
34,940
4,689
360,426
221,062
83,824
77,750
162,320
290,340
226,523
233,775
300,924
321,052
6,713,944
13,222,800
13,884,600
13,884,60013,222,8006,713,944321,052300,924233,775226,523290,340162,32077,75083,824221,062360,4264,68934,94037,0993,715700
       Other Assets 
0
0
0
0
0
0
0
0
107,116
177,485
7
99,678
110,285
88,967
105,270
133,847
241,556
123,835
0
0123,835241,556133,847105,27088,967110,28599,6787177,485107,11600000000
> Total Liabilities 
1,748,994
2,938,307
2,882,825
2,774,224
2,688,505
3,078,371
2,278,460
2,799,288
3,082,008
4,923,728
4,620,571
3,081,891
3,205,601
3,080,748
3,755,708
4,246,853
4,687,893
10,735,200
10,708,000
10,708,00010,735,2004,687,8934,246,8533,755,7083,080,7483,205,6013,081,8914,620,5714,923,7283,082,0082,799,2882,278,4603,078,3712,688,5052,774,2242,882,8252,938,3071,748,994
   > Total Current Liabilities 
638,656
1,009,739
764,521
858,075
1,162,401
1,225,087
1,883,222
2,389,732
2,762,704
4,597,491
4,357,995
2,812,084
2,749,006
2,432,357
3,128,460
3,452,737
3,837,156
5,544,500
8,682,300
8,682,3005,544,5003,837,1563,452,7373,128,4602,432,3572,749,0062,812,0844,357,9954,597,4912,762,7042,389,7321,883,2221,225,0871,162,401858,075764,5211,009,739638,656
       Short-term Debt 
0
0
0
0
0
0
552,265
368,766
813,927
1,266,160
1,930,207
488,603
292,928
257,977
369,891
398,465
339,412
1,739,100
3,443,800
3,443,8001,739,100339,412398,465369,891257,977292,928488,6031,930,2071,266,160813,927368,766552,265000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
932,032
883
4,000
488,603
292,928
257,977
320,361
326,446
263,150
1,650,200
3,335,000
3,335,0001,650,200263,150326,446320,361257,977292,928488,6034,000883932,03200000000
       Accounts payable 
258,744
634,848
441,476
386,560
455,032
504,488
370,902
605,076
607,478
775,139
908,509
989,771
1,103,950
827,606
1,237,925
1,869,234
2,244,797
2,386,400
3,563,100
3,563,1002,386,4002,244,7971,869,2341,237,925827,6061,103,950989,771908,509775,139607,478605,076370,902504,488455,032386,560441,476634,848258,744
       Other Current Liabilities 
379,912
374,891
323,045
471,515
707,369
720,599
787,496
70,727
91,648
2,440
219,974
10
1
7,132
16,486
99,404
88,201
236,500
1,557,800
1,557,800236,50088,20199,40416,4867,132110219,9742,44091,64870,727787,496720,599707,369471,515323,045374,891379,912
   > Long-term Liabilities 
1,110,338
1,928,568
2,118,304
1,916,149
1,526,104
1,853,284
395,238
409,556
319,304
326,237
262,576
269,807
456,595
648,391
627,248
794,116
850,737
5,190,700
2,025,700
2,025,7005,190,700850,737794,116627,248648,391456,595269,807262,576326,237319,304409,556395,2381,853,2841,526,1041,916,1492,118,3041,928,5681,110,338
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,292
51,414
206,176
3,985,413
0
03,985,413206,17651,41412,29200000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
314,420
322,236
310,152
269,807
456,595
648,391
680,735
742,702
644,561
0
0
00644,561742,702680,735648,391456,595269,807310,152322,236314,42000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,576
0
0
0
0
0
000001,5760000000000000
> Total Stockholder Equity
3,303,768
4,184,620
4,530,246
4,688,915
5,681,175
6,915,425
9,699,529
10,202,712
10,428,124
9,948,742
10,937,310
13,636,690
14,415,580
14,801,224
14,354,893
18,097,248
21,341,230
24,803,500
29,233,300
29,233,30024,803,50021,341,23018,097,24814,354,89314,801,22414,415,58013,636,69010,937,3109,948,74210,428,12410,202,7129,699,5296,915,4255,681,1754,688,9154,530,2464,184,6203,303,768
   Common Stock
160,736
168,653
168,653
168,653
168,653
169,034
169,415
169,415
169,463
169,616
169,640
169,640
167,140
160,473
154,564
154,564
154,564
154,800
155,200
155,200154,800154,564154,564154,564160,473167,140169,640169,640169,616169,463169,415169,415169,034168,653168,653168,653168,653160,736
   Retained Earnings 
3,143,032
4,015,865
4,361,593
4,520,262
5,512,522
6,746,391
4,134,110
4,543,494
4,792,480
4,312,287
5,405,686
8,066,148
9,291,153
11,024,320
12,329,467
15,847,935
18,427,069
22,757,071
25,132,989
25,132,98922,757,07118,427,06915,847,93512,329,46711,024,3209,291,1538,066,1485,405,6864,312,2874,792,4804,543,4944,134,1106,746,3915,512,5224,520,2624,361,5934,015,8653,143,032
   Accumulated Other Comprehensive Income 
-722,943
-839,421
-1,006,250
-1,198,568
-1,398,924
-1,581,313
-1,761,508
-1,984,851
-2,244,564
-2,664,627
-3,058,092
-3,503,110
-4,045,777
-4,534,457
-5,154,102
1,583,581
2,248,429
2,698,761
29,078,100
29,078,1002,698,7612,248,4291,583,581-5,154,102-4,534,457-4,045,777-3,503,110-3,058,092-2,664,627-2,244,564-1,984,851-1,761,508-1,581,313-1,398,924-1,198,568-1,006,250-839,421-722,943
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
507,682
507,682
507,682
507,682
507,682
507,682
507,682
697,292
0
0697,292507,682507,682507,682507,682507,682507,682507,6820000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
722,943
839,523
1,006,250
1,198,568
1,398,924
1,581,313
7,157,512
7,474,654
7,710,745
8,131,466
8,420,076
8,904,012
9,003,064
-14,299,240
-13,888,267
511,168
511,168
-807,132
-25,132,989
-25,132,989-807,132511,168511,168-13,888,267-14,299,2409,003,0648,904,0128,420,0768,131,4667,710,7457,474,6547,157,5121,581,3131,398,9241,198,5681,006,250839,523722,943



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue34,841,800
Cost of Revenue-19,217,800
Gross Profit15,624,00015,624,000
 
Operating Income (+$)
Gross Profit15,624,000
Operating Expense-8,038,300
Operating Income7,585,7007,585,700
 
Operating Expense (+$)
Research Development356,715
Selling General Administrative337,026
Selling And Marketing Expenses3,818,072
Operating Expense8,038,3004,511,813
 
Net Interest Income (+$)
Interest Income44,277
Interest Expense-443,300
Other Finance Cost-44,277
Net Interest Income-443,300
 
Pretax Income (+$)
Operating Income7,585,700
Net Interest Income-443,300
Other Non-Operating Income Expenses0
Income Before Tax (EBT)7,515,1007,656,300
EBIT - interestExpense = 7,142,396
7,515,078
5,969,578
Interest Expense443,300
Earnings Before Interest and Taxes (EBIT)7,585,6967,958,400
Earnings Before Interest and Taxes (EBITDA)8,968,900
 
After tax Income (+$)
Income Before Tax7,515,100
Tax Provision-1,988,800
Net Income From Continuing Ops5,526,3005,526,300
Net Income5,526,278
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses27,256,100
Total Other Income/Expenses Net-70,600443,300
 

Technical Analysis of JB Chemicals & Pharmaceuticals Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of JB Chemicals & Pharmaceuticals Limited. The general trend of JB Chemicals & Pharmaceuticals Limited is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine JB Chemicals & Pharmaceuticals Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of JB Chemicals & Pharmaceuticals Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1,897 < 1,970 < 1,992.

The bearish price targets are: 1,731 > 1,695 > 1,684.

Tweet this
JB Chemicals & Pharmaceuticals Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of JB Chemicals & Pharmaceuticals Limited. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

JB Chemicals & Pharmaceuticals Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of JB Chemicals & Pharmaceuticals Limited. The current macd is 11.48.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the JB Chemicals & Pharmaceuticals Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for JB Chemicals & Pharmaceuticals Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the JB Chemicals & Pharmaceuticals Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
JB Chemicals & Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) ChartJB Chemicals & Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of JB Chemicals & Pharmaceuticals Limited. The current adx is 12.84.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy JB Chemicals & Pharmaceuticals Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
JB Chemicals & Pharmaceuticals Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of JB Chemicals & Pharmaceuticals Limited. The current sar is 1,812.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
JB Chemicals & Pharmaceuticals Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of JB Chemicals & Pharmaceuticals Limited. The current rsi is 60.79. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
JB Chemicals & Pharmaceuticals Limited Daily Relative Strength Index (RSI) ChartJB Chemicals & Pharmaceuticals Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of JB Chemicals & Pharmaceuticals Limited. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the JB Chemicals & Pharmaceuticals Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
JB Chemicals & Pharmaceuticals Limited Daily Stochastic Oscillator ChartJB Chemicals & Pharmaceuticals Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of JB Chemicals & Pharmaceuticals Limited. The current cci is 101.75.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
JB Chemicals & Pharmaceuticals Limited Daily Commodity Channel Index (CCI) ChartJB Chemicals & Pharmaceuticals Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of JB Chemicals & Pharmaceuticals Limited. The current cmo is 31.73.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
JB Chemicals & Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) ChartJB Chemicals & Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of JB Chemicals & Pharmaceuticals Limited. The current willr is -9.91712707.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
JB Chemicals & Pharmaceuticals Limited Daily Williams %R ChartJB Chemicals & Pharmaceuticals Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of JB Chemicals & Pharmaceuticals Limited. The current atr is 62.76.

JB Chemicals & Pharmaceuticals Limited Daily Average True Range (ATR) ChartJB Chemicals & Pharmaceuticals Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of JB Chemicals & Pharmaceuticals Limited. The current obv is 15,613,227.

JB Chemicals & Pharmaceuticals Limited Daily On-Balance Volume (OBV) ChartJB Chemicals & Pharmaceuticals Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of JB Chemicals & Pharmaceuticals Limited. The current mfi is 67.90.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
JB Chemicals & Pharmaceuticals Limited Daily Money Flow Index (MFI) ChartJB Chemicals & Pharmaceuticals Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for JB Chemicals & Pharmaceuticals Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

JB Chemicals & Pharmaceuticals Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of JB Chemicals & Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.791
Ma 20Greater thanMa 501,852.905
Ma 50Greater thanMa 1001,885.058
Ma 100Greater thanMa 2001,863.386
OpenGreater thanClose1,865.600
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of JB Chemicals & Pharmaceuticals Limited with someone you think should read this too:
  • Are you bullish or bearish on JB Chemicals & Pharmaceuticals Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about JB Chemicals & Pharmaceuticals Limited

I send you an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited.


Comments

How you think about this?

Leave a comment

Stay informed about JB Chemicals & Pharmaceuticals Limited.

Receive notifications about JB Chemicals & Pharmaceuticals Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.